These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10515668)

  • 21. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis.
    Shah NR; Borenstein J; Dubois RW
    Menopause; 2005; 12(6):668-78. PubMed ID: 16278609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and breast cancer.
    Kenemans P; Stampfer M
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):1-4. PubMed ID: 8789741
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Van Leeuwen FE; Rookus MA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575989
    [No Abstract]   [Full Text] [Related]  

  • 24. Summaries for patients. Alcohol, postmenopausal hormone therapy, and breast cancer.
    Ann Intern Med; 2002 Nov; 137(10):I43. PubMed ID: 12435234
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contradictory hormone studies renew debate over breast cancer link.
    Am J Health Syst Pharm; 1995 Oct; 52(19):2066, 2076. PubMed ID: 8535935
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 30. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
    J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer and hormone-replacement therapy.
    Joseph KS
    N Engl J Med; 1995 Nov; 333(20):1356; author reply 1357-8. PubMed ID: 7566035
    [No Abstract]   [Full Text] [Related]  

  • 33. Postmenopausal hormone therapy and breast cancer: what is the problem?
    Kenemans P
    Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: "Increased risk of breast cancer with alcohol consumption in postmenopausal women".
    Friedenreich CM
    Am J Epidemiol; 1994 Mar; 139(5):541-2. PubMed ID: 8154479
    [No Abstract]   [Full Text] [Related]  

  • 36. Weighing the risks and benefits of hormone therapy.
    Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E
    JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormone therapy as risk factor of breast cancer modulated by diagnostic and lifestyle risk factors in Taiwan-A National Cohort study.
    Chiang PH; Tang FH; Tsai EM; Chang YC; Yang CY
    Breast J; 2019 May; 25(3):531-534. PubMed ID: 30701626
    [No Abstract]   [Full Text] [Related]  

  • 38. [Benefits and risks in hormone substitute therapy in postmenopause].
    Baljić T
    Srp Arh Celok Lek; 1996; 124(5-6):143-6. PubMed ID: 9102835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HRT, cancer and cardiovascular disease--second thoughts?
    Davey DA
    S Afr Med J; 2000 Oct; 90(10):994-6. PubMed ID: 11081103
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increased risk of breast cancer following estrogen substitution after all? Hormone substitution in peri- and postmenopause--Swedish studies].
    von Werder K
    Fortschr Med; 1989 Nov; 107(34):723-4. PubMed ID: 2606417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.